The majority of primary bloodstream infections (BSI) originate from central lines (CLs) and present a significant risk for hospitalized patients, particularly for those in intensive care units (ICUs). Central line-associated blood stream infections (CLABSI) extend hospitalization, and increase both associated costs and mortality [1] .
Intravenous (IV) fluid contamination may occur during setup, admixture preparation, and administration [2, 3] . Additional risks for extrinsic contamination are incurred when the infusion system is vented, as is the case with open infusion containers.
Two types of IV infusion systems (open and closed) are in use worldwide [4, 5] . Open infusion containers consist of rigid (glass, burette) or semi-rigid plastic containers that must admit air (air filter or needle) in order to empty the solution from the container. Closed infusion containers consist of fully collapsible plastic bags that do not require or use any external vent (air filter or needle) to empty the solution, and the injection ports are self-sealing. Closed infusion containers ensure a consistent, even infusion rate throughout the administration process without the assistance of a mechanical device (e.g., infusion pump). Product integrity must be maintained during extreme usage conditions and there should be no leakage.
Closed systems are being incorporated into standard practice to prevent CLABSI. Numerous countries have reported CLABSI outbreaks resulting from contaminated infusate in open infusion systems [2, [6] [7] [8] [9] [10] . Other studies have established extrinsic or in-use contamination as the most significant contributing factor in the bacterial contamination of infusion systems [11, 12] . In a study conducted in Argentina, switching from open (semi-rigid plastic) to closed infusion containers resulted in a 64% reduction in the rate of CLABSI [5] .
The impact of switching from an open to a closed infusion container on CLABSI has not been previously investigated in Brazil. In this study, we report the results of a prospective, sequential study undertaken to determine the impact of switching from an open (glass or semi-rigid plastic) to a closed infusion container on both the rate and time to onset of CLABSI in Brazil.
Material and Methods

Setting
This study was conducted in three ICUs at Santa Marcelina Hospital, a teaching hospital in Sao Paulo, Brazil, with the approval of the hospital Ethics Committee. The hospital has an active infection control program, with two physicians trained in infectious diseases and three infection control nurses. The three ICUs operate at the highest level of complexity in Brazil, providing treatment for medical, surgical, and trauma patients.
Data Collection
Patients who had a CL in place for ≥24 hours were enrolled from each of the study ICUs. Patient gender, average severity-of-illness score on ICU entry [13] , device utilization, antibiotic exposure, and all active infections identified while in the ICU were prospectively recorded on case report forms by a trained nurse. Blood cultures were obtained at the discretion of the patients' physicians. Standard laboratory methods were used to identify microorganisms recovered from positive blood cultures [14] .
Definitions
United States Centers for Disease Control (CDC) National Nosocomial Infections Surveillance Systems (NNIS) program definitions were used to define device-associated infections: CLABSI was defined as either laboratory confirmed BSI (LCBSI) or clinical primary nosocomial sepsis (CSEP) [15] .
An open infusion container was defined as a rigid (glass, burette) or semi-rigid plastic container that must admit air to empty (air filter or needle). A closed infusion container was defined as a fully collapsible, plastic bag that does not require or use any external vent (air filter or needle) to empty the solution, and has injection ports that are self-sealing.
Investigational Products
Baxter Viaflex® (Baxter Hospitalar Ltda, Brazil), a fully collapsible plastic bag, was used during the closed infusion container period. Commercially available open infusion containers (glass and semi-rigid plastic containers) were used during the open infusion container period.
Study Design
Active surveillance for CLABSI and compliance with infection control practices were conducted throughout the study using CDC NNIS methodologies, definitions, and criteria [13] . The open infusion container period was followed by the Hand hygiene compliance prior to patient contact, aseptic procedures [16] , placement of gauze on CL insertion sites, condition of gauze dressing (absence of blood, moisture, and gross soilage; occlusive coverage of insertion site) [17, 18] , and documentation for date of CL insertion were assessed during the study. Healthcare workers (physicians, nurses, and paramedical staff) were observed three times weekly across all work shifts by a research nurse who recorded relevant information on a standard form.
Data Analysis
Outcomes measured during the open and closed infusion container periods included the incidence density rate of CLABSI (number of cases per 1000 CL days) and time to CLABSI. Chi-square analyses for dichotomous variables and t-test for continuous variables were used to analyze baseline differences between container periods. Relative risk (RR) ratios, 95% confidence intervals (CIs), and P-values were determined for all outcomes. Time to first CLABSI was analyzed using a log-rank test and is presented graphically using Kaplan-Meier curves. Simple life table conditional probabilities also are presented graphically to help explain the changing risk of infection over time (Figure 1) .
Results
A total of 1,125 patients were enrolled in the study: 483 during the open infusion container period and 642 during the closed infusion container period. Patients in both container periods were statistically similar with respect to demographics, average severity of illness score, and underlying illness (except for endocrine disease, cardiac failure, cardiac surgery, chronic obstructive pulmonary disease, abdominal surgery, immunocompromise, and urinary catheter and mechanical ventilator exposure) ( Table 1) .
Hand hygiene compliance exceeded 60% during both periods (65.4% and 63.9% during the open and closed infusion container periods, respectively, RR = 0.98; and 95% CI = 0.94 -1.02).
Presence of gauze at the CL site was 99.5% and 100% during the open and closed infusion container periods, respectively (RR = 1.01; 95% CI = 1.00 -1.01). Compliance with protocol-prescribed condition of gauze was 98.6% and 99.7% during the open and closed infusion container periods, respectively (RR = 1.01; 95% CI = 1.01 -1.02). Presence of the date at the CL insertion site/administration set was 100% during both the open and closed infusion container periods.
Both the incidence density rate and the percentage of patients with CLABSI were statistically significantly lower in the closed compared to the open infusion container period ( Table 2 ). The distribution of microorganisms during both container periods is shown in Table 3 .
In this study, we compared the open and closed infusion container periods with respect to time to acquisition of first CLABSI (Table 4) . When examined at three-day intervals, the conditional probability of acquiring a CLABSI during the closed infusion container period was observed to be relatively constant (Table 4) . During the open infusion container period, the conditional probability of acquiring a CLABSI was higher in each three-day interval compared to the corresponding three-day intervals in the closed infusion container period. The conditional probability of acquiring a CLABSI in the open infusion container period ranged from 1.5% at Days 2-4 to 2.3% at Days 11-13. Combined across all time intervals, the chance of a patient acquiring a CLABSI was significantly lower (55%) in the closed infusion container period (Cox proportional hazard ratio 0.45, p= 0.019). Cumulative results are shown in Figure 1 .
Discussion
Seriously ill patients frequently require CL access for administration of large volumes of IV fluid, medications, and blood products, or for hemodynamic monitoring. It is well Table 1 . Patient demographics, underlying illness, length of stay, device utilization, and antibiotic usage during the two study periods. Table 2 . Incidence of CLABSI during the two study periods.
known that the use of CLs poses a significant increase in the risk of CLABSI [4, [19] [20] [21] [22] [23] .
In various studies, increases in length of stay, cost, and attributable mortality have all been reported as consequences of CLABSI [1, [24] [25] [26] [27] . In Argentina, Rosenthal et al. found that CLABSI resulted in an extra 12 days of hospitalization and 4,888 US dollars in costs [1] . Likewise, Higuera et al. reported that CLABSI in Mexico resulted in an extra six days of hospitalization and 11,560 US dollars in costs [25] .
CLABSIs are apparently related to increased attributable mortality: Collignon [28] reported that CLABSIs resulted in excess mortality of 12% in Australia, while Pittet et al. [29, 30] found an attributable mortality of 25% in a study conducted in the United States. Similarly, CLABSIs are responsible for excess mortality in both South and Central America. In a study of medical/surgical ICUs in Argentina, Rosenthal et al. found an attributable mortality rate of 25% [31] , and in a recent study of ICUs in Mexico, Higuera et al. [25] found an attributable mortality rate of 20%. CLABSIs can be prevented [32, 33] . Simple interventions such as use of maximal barrier precautions [34] and use of chlorhexidine rather than iodophors for cutaneous antisepsis [35] have resulted in decreased incidence of CLABSI in randomized trials [34] . Performance monitoring and feedback were also effective in reducing rates of CLABSI [17, 18] .
In a study conducted in a medical ICU of Brazil by Lobo et al., the rate of CLABSI was 20.0 per 1000 CL days. A multifaceted program including an educational strategy targeted to specific problems observed during careful evaluation of CL care practices, decreased the presence of Staphylococcus aureus and nearly halved the CLABSI rate to 11.0 per 1000 CL days. During the year that followed implementation of the educational intervention, the CLABSI rate remained similar at 12.0 per 1000 CL days [36] .
Use of closed infusion systems has also reduced the risk of extrinsic contamination during IV administration in the hospital setting. Intrinsic contamination of parenteral fluids (microorganisms introduced during or prior to manufacturing) is almost nonexistent in the United States. Contamination of the infusate or catheter hubs has been associated with most epidemics of infusion-related CLABSIs. However, in several countries, hospitals continue to use open (glass, burette, or semi-rigid plastic), externally vented (with or without air filters) infusion containers, thereby increasing the risk of extrinsic contamination, especially by Gram-negative bacilli, which can multiply rapidly in commercial IV admixtures [3, 6, [37] [38] [39] . Closed infusion containers have been developed to reduce this risk. However, as published in other studies, open systems are still widely used in a number of hospitals in different countries [4, [19] [20] [21] 31, 40] .
In this study, open infusion containers were associated with a higher rate of CLABSI which was reduced significantly when switching to a closed infusion containers. The magnitude of the difference in CLABSI rate between the open versus closed infusion container increased over time. Looking at the CLABSI rate per 1000 CL days, only the closed infusion container period achieved levels reported in the NNIS.
Prior investigation published in 2004 did not include analysis of time to CLABSI [5] . In our study, we demonstrated that if the patient receives infusate via an open infusion container, the risk of acquiring CLABSI increases over time. When using a closed infusion container, the probability of acquiring a CLABSI remains relatively constant, and if the patient acquires a CLABSI, it would occur significantly latter; suggesting that closed infusion containers reduce risk of CLABSI acquisition over time. Subsequently, the use of a closed infusion containers could especially benefit those patients with more severe illness who may require CLs for longer periods of time. The delayed onset of CLABSI may also benefit patients with CLs early during the course of treatment when their underlying illness might be most severe.
There were limitations in this study. Participants were not concurrently randomized to the two infusion containers (open and closed). It was logistically not practical to blind the study.
However, this may have mitigated the selection bias that might occur in an open label, randomized study. Also, the study design did not allow for determination of epidemiologic mechanisms responsible for the striking differences in outcome (e.g., reduced contamination of infusate).
Conclusion
In this study we have shown that switching from an open to a closed infusion container (fully collapsible plastic bag with no requirement for/use of external venting [air filter or needle], and self-sealing injection ports), as adopted in developed countries in North America and Western Europe, significantly diminishes the rate and risk of CLABSI.
